NCT02889068View on ClinicalTrials.gov

Targeted Next Generation Sequencing and Intellectual Disability

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

January 30, 2017

Conditions
Intellectual Disability
Interventions
OTHER

Blood sample

Trial Locations (1)

54511

Chru Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT02889068 - Targeted Next Generation Sequencing and Intellectual Disability | Biotech Hunter | Biotech Hunter